Lifesciences@Work : We help scientists build their business


Current treatment options are inadequate and reflect an urgent need for disease modifying drugs. The company’s proprietary technology platform allows the successful development of treatments that focus on restoring cartilage and bone, thereby addressing an important unmet medical need in today’s society.

Having two advanced therapeutic prgorammes with a strong technology and IP position, Arcarios is well positioned to capitalise on market opportunities in the field of osteoarthritis and osteoporosis.